The expression of IGFBP3 was significantly increased in matching liver metastatic samples compared with primary CRC and adjacent noncancerous tissue by immunohistochemistry in the cohort of patients (Fig. 1C, D). The gene discussed is IGFBP3; the disease is colorectal carcinoma.